Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors

被引:10
|
作者
Zhou, Xuan [1 ]
Zhang, Xueyan [1 ]
Zhong, Tangsheng [1 ]
Zhou, Meng [1 ]
Gao, Lan [2 ,4 ]
Chen, Li [1 ,3 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Changchun, Peoples R China
[3] Jilin Univ, Sch Nursing, 965 Xinjiang St, Changchun 130021, Jilin, Peoples R China
[4] First Hosp Jilin Univ, 71 Xinmin St, Changchun 130031, Jilin, Peoples R China
关键词
breast cancer; chemotherapy-related cognitive impairment; nursing; systematic review; older adults; CHEMOBRAIN; ADULTS; AGE;
D O I
10.1111/jan.15842
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
AimsTo examine the prevalence and associated factors of chemotherapy-related cognitive impairment (CRCI) in older breast cancer survivors (BCS).DesignSystematic review.Data SourcesWe searched EMBASE, PubMed, PsychInfo, CINAHL, Cochrance Library, Web of Science, CNKI and SinoMed, without language restrictions, for studies published from the establishment of the database to September 2022.Review MethodsTwo researchers independently examined the full texts, data extraction and quality assessment, and any discrepancies were resolved through discussion with a third reviewer. Quality of evidence was assessed using the Newcastle-Ottawa Scale and the Agency for Healthcare Research and Quality Scale.ResultsThe seven included studies showed that the estimated prevalence of CRCI in older BCS ranged from 18.6% to 27% on objective neuropsychological tests and from 7.6% to 49% on subjective cognitive assessments. The areas most affected were attention, memory, executive functioning and processing speed. CRCI was associated with 10 factors in six categories, including sociodemographic (e.g. age, education level), physiological (e.g. sleep disorders, fatigue and comorbidities), psychological (e.g. anxiety, depression), treatment modalities (e.g. chemotherapy cycles, chemotherapy regimens), genetic (e.g. APOE2, APOE4) and lifestyle factor (e.g. physical inactivity).ConclusionCRCI is multifactorial and has a relatively high prevalence. However, the results of subjective and objective cognitive examinations were inconsistent, possibly due to variations in tools used to evaluate different definitions of CRCI. Nevertheless, as there are few published studies of older BCS, this conclusion still require verification by well-designed studies in the future.ImpactWe found that the prevalence of CRCI in older adults is relatively high and multifactorial, providing evidence for further health care for this population.No Patient or Public ContributionThere was no patient or public involvement.
引用
收藏
页码:484 / 499
页数:16
相关论文
共 50 条
  • [21] Potential factors associated with perceived cognitive impairment in breast cancer survivors
    Jamie S. Myers
    Jo A. Wick
    Jennifer Klemp
    Supportive Care in Cancer, 2015, 23 : 3219 - 3228
  • [22] Potential factors associated with perceived cognitive impairment in breast cancer survivors
    Myers, Jamie S.
    Wick, Jo A.
    Klemp, Jennifer
    SUPPORTIVE CARE IN CANCER, 2015, 23 (11) : 3219 - 3228
  • [23] Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis
    Duran-Gomez, Noelia
    Lopez-Jurado, Casimiro Fermin
    Nadal-Delgado, Marta
    Perez-Civantos, Demetrio
    Guerrero-Martin, Jorge
    Caceres, Macarena C.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [24] Chemotherapy-related cognitive impairment and kidney dysfunction
    Simeoni, Mariadelina
    Mulholland, Michele M.
    Workeneh, Biruh T.
    Capasso, Anna
    Hafez, Gaye
    Liabeuf, Sophie
    Malyszko, Jolanta
    Mani, Laila-Yasmin
    Trevisani, Francesco
    De, Ananya
    Wagner, Carsten A.
    Massy, Ziad A.
    Unwin, Robert
    Capasso, Giovambattista
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 : ii54 - ii63
  • [25] A Drosophila model of chemotherapy-related cognitive impairment
    Torre, M.
    Feany, M.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 539 - 540
  • [26] Neural correlates of chemotherapy-related cognitive impairment
    Kaiser, Jochen
    Bledowski, Christoph
    Dietrich, Joerg
    CORTEX, 2014, 54 : 33 - 50
  • [27] Neuropsychologic Testing for Chemotherapy-Related Cognitive Impairment
    Myers, Jamie S.
    CHEMO FOG: CANCER CHEMOTHERAPY-RELATED COGNITIVE IMPARIMENT, 2010, 678 : 55 - 69
  • [28] The Promise of Nutrient-Derived Bioactive Compounds and Dietary Components to Ameliorate Symptoms of Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
    Kumar, Nagi B.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (08)
  • [29] The Promise of Nutrient-Derived Bioactive Compounds and Dietary Components to Ameliorate Symptoms of Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
    Nagi B. Kumar
    Current Treatment Options in Oncology, 2021, 22
  • [30] Cancer-related cognitive impairment and associated factors in a sample of older male oral-digestive cancer survivors
    Regier, Natalie G.
    Naik, Aanand D.
    Mulligan, Elizabeth A.
    Nasreddine, Ziad S.
    Driver, Jane A.
    Sada, Yvonne H-F
    Moye, Jennifer
    PSYCHO-ONCOLOGY, 2019, 28 (07) : 1551 - 1558